These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 6375863)
1. Some thoughts on resistance to cancer chemotherapy. Carter SK Cancer Treat Rev; 1984 Mar; 11 Suppl A():3-7. PubMed ID: 6375863 [No Abstract] [Full Text] [Related]
2. The forty-year-old mutation theory of Luria and Delbrück and its pertinence to cancer chemotherapy. Skipper HE Adv Cancer Res; 1983; 40():331-63. PubMed ID: 6362357 [No Abstract] [Full Text] [Related]
3. The use of cell kinetics in the development of drug combinations. Valeriote FA Pharmacol Ther; 1979; 4(1):1-33. PubMed ID: 461499 [No Abstract] [Full Text] [Related]
4. Clinical aspects of drug resistance. Holland JF Antibiot Chemother (1971); 1978; 23():238-46. PubMed ID: 348082 [No Abstract] [Full Text] [Related]
5. Rationale for the use of alternating non-cross-resistant chemotherapy. Goldie JH; Coldman AJ; Gudauskas GA Cancer Treat Rep; 1982 Mar; 66(3):439-49. PubMed ID: 7060033 [No Abstract] [Full Text] [Related]
6. New thoughts on resistance to chemotherapy. Goldie JH Hosp Pract (Off Ed); 1983 May; 18(5):165-9, 173-7. PubMed ID: 6404792 [TBL] [Abstract][Full Text] [Related]
7. Cancer chemotherapy. The relevance of certain concepts of cell cycle kinetics. Hill BT Biochim Biophys Acta; 1978 Dec; 516(4):389-417. PubMed ID: 361085 [No Abstract] [Full Text] [Related]
8. The experimental basis for combination chemotherapy. van Putten LM Cancer Treat Rev; 1984 Mar; 11 Suppl A():19-23. PubMed ID: 6733718 [No Abstract] [Full Text] [Related]
9. Combination chemotherapy--theory and practice. Capizzi RL; Keiser LW; Sartorelli AC Semin Oncol; 1977 Jun; 4(2):227-53. PubMed ID: 327555 [No Abstract] [Full Text] [Related]
10. Clinical concepts derived from animal chemotherapy studies. Goldin A; Schabel FM Cancer Treat Rep; 1981; 65 Suppl 3():11-9. PubMed ID: 7049366 [TBL] [Abstract][Full Text] [Related]
11. The role of cell kinetics in cancer chemotherapy. Valeriote FA; Edelstein MB Semin Oncol; 1977 Jun; 4(2):217-26. PubMed ID: 327554 [No Abstract] [Full Text] [Related]
12. Modelling the process of drug resistance. Goldie JH Lung Cancer; 1994 Mar; 10 Suppl 1():S91-6. PubMed ID: 7916254 [TBL] [Abstract][Full Text] [Related]
13. A model for metastases formation. Markovitch S Int J Biomed Comput; 1993 Jan; 32(1):19-33. PubMed ID: 8425750 [TBL] [Abstract][Full Text] [Related]
14. Individual cell biology: basis and prospects for a rational cancer chemotherapy. Tanneberger S Arch Geschwulstforsch; 1977; 47(8):755-65. PubMed ID: 345995 [No Abstract] [Full Text] [Related]
15. A mathematical model of the development of drug resistance to cancer chemotherapy. Birkhead BG; Rankin EM; Gallivan S; Dones L; Rubens RD Eur J Cancer Clin Oncol; 1987 Sep; 23(9):1421-7. PubMed ID: 3678329 [TBL] [Abstract][Full Text] [Related]
17. A quantitative approach to the design of antitumor drug dosage schedule via cell cycle kinetics and systems theory. Kim M; Woo KB; Perry S Ann Biomed Eng; 1977 Mar; 5(1):12-33. PubMed ID: 557938 [No Abstract] [Full Text] [Related]
18. Alternation of chemotherapy and radiotherapy in cancer management. I. Summary of the Division of Cancer Treatment Workshop. Looney WB; Goldie JH; Little JB; Hopkins HA; Read EJ; Wittes R Cancer Treat Rep; 1985; 69(7-8):769-75. PubMed ID: 4016787 [No Abstract] [Full Text] [Related]
19. Role of mathematical modeling in protocol formulation in cancer chemotherapy. Coldman AJ; Goldie JH Cancer Treat Rep; 1985 Oct; 69(10):1041-8. PubMed ID: 2412691 [TBL] [Abstract][Full Text] [Related]
20. Intrinsic versus acquired drug resistance. Mackillop WJ Cancer Treat Rep; 1986 Jun; 70(6):817-8. PubMed ID: 3731144 [No Abstract] [Full Text] [Related] [Next] [New Search]